MBHB Partner Kevin Noonan Quoted in Nature Article Entitled, “Major CRISPR Patent Decision Won’t End Tangled Dispute”
March 9, 2022
McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D., comments on the Patent Trial and Appeal Board’s recent CRISPR ruling in Nature. View the article
